Across the country, state lawmakers are considering ways to address the risks posed by the explosion of power-hungry data centers. They have proposed an array of bills to impose moratoriums on data ...

Explore common Python backtesting pain points, including data quality issues, execution assumptions, and evaluation ...

In this week’s Crypto Long & Short Newsletter, Ruchir Gupta writes on how we’re moving toward a true fixed-income market for crypto-native yield. Then, Clara García Prieto on bitcoin becoming ...

The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective strategies. Objectives: Provider organizations are increasingly entering ...

Third-party apps, aftermarket parts, and hidden settings can make your Peloton experience so much better.

Windows has always been built for power users who automate. Now, OpenClaw and cloud APIs like WayinVideo are ushering in a new era of truly autonomous desktop workflows — here's what that looks like ...

Welcome to Comtech Telecommunications Corp.'s Conference Call for the Second Quarter of Fiscal 2026. As a reminder, this conference call is being recorded. I would now like to turn the call over to ...

Lens AI, powered by the proprietary HIFT system, advanced functional adjacency capabilities and identified a single conserved functional feature across 2,000+ influenza sequences. Dengue Pipeline -- ...

Zapier reports on the importance of AI governance, emphasizing its role in ethical, secure, and responsible AI use while managing risks and building trust.

Good afternoon, and welcome to Arthur J. Gallagher & Company's quarterly investor meeting with management. [Operator Instructions] Today's call is being recorded. If you have any objections, you may ...

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...